Parp inhibitors as maintenance treatment in platinum sensitive recurrent ovarian cancer: An updated meta-analysis of randomized clinical trials according to BRCA …

F Tomao, E Bardhi, A Di Pinto, CM Sassu… - Cancer Treatment …, 2019 - Elsevier
Objective This meta-analysis investigated the effectiveness of PARP inhibitors (PARPis) as
maintenance treatment in platinum sensitive recurrent ovarian cancer (ROC), stratifying …

Modified fragility index and surgical complexity score are able to predict postoperative morbidity and mortality after cytoreductive surgery for advanced ovarian cancer

V Di Donato, A Di Pinto, A Giannini, G Caruso… - Gynecologic …, 2021 - Elsevier
Objective The aim of this study was to assess the impact of surgical complexity on postoperative
complications and mortality, according to patient's frailty (mFI) following surgery for …

[HTML][HTML] Survival nomograms after curative neoadjuvant chemotherapy and radical surgery for stage IB2-IIIB cervical cancer

C Marchetti, F De Felice, A Di Pinto… - Cancer Research and …, 2018 - ncbi.nlm.nih.gov
Purpose The purpose of this study was to develop nomograms for predicting the probability
of overall survival (OS) and progression-free survival (PFS) in locally advanced cervical …

Overcoming platinum resistance in ovarian cancer treatment: from clinical practice to emerging chemical therapies

…, A Romito, A Di Pinto, V Di Donato… - Expert opinion on …, 2017 - Taylor & Francis
Introduction: The objective of this review is to summarize results from clinical trials that tested
cytotoxic drugs and target strategies for the treatment of platinum resistant (PR) recurrent …

PD-L1 expression is associated with tumor infiltrating lymphocytes that predict response to NACT in squamous cell cervical cancer

…, A Di Pinto, L Musacchio, M Leopizzi, V Di Maio… - Virchows Archiv, 2021 - Springer
… and Di Pinto Anna collected and critically analyzed clinical data; Tomao Federica contributed
to statistical analysis; Musacchio Lucia collected clinical data; Leopizzi Martina and Di

Prevention of recurrent lower urinary tract infections in postmenopausal women with genitourinary syndrome: outcome after 6 months of treatment with ospemifene

…, A Di Pinto, V Sciuga, P Faiano, C Di Tucci… - Gynecological …, 2018 - Taylor & Francis
Aim of this study was to evaluate the efficacy of ospemifene in the prevention of recurrent
lower urinary tract infections in postmenopausal women with vulvovaginal atrophy. The study …

[HTML][HTML] Fertility preservation in gynaecologic cancers

F De Felice, C Marchetti, A Di Pinto… - …, 2018 - ncbi.nlm.nih.gov
Due to substantial improvement in the diagnosis and treatment of gynaecologic cancers, a
better understanding of patient care needs to be revised. We reviewed the literature related to …

[HTML][HTML] Hepatobiliary disease resection in patients with advanced epithelial ovarian cancer: prognostic role and optimal cytoreduction

…, A Giannini, O D'Oria, MC Schiavi, A Di Pinto… - Annals of Surgical …, 2021 - Springer
Objective The purpose of this study was to evaluate the feasibility and safety in terms of
prognostic significance and perioperative morbidity and mortality of cytoreduction in patients …

Does hormone replacement therapy impact the prognosis in endometrial cancer survivors? A systematic review

…, D D'Aniello, L Musacchio, G Santangelo, A Di Pinto… - Oncology, 2020 - karger.com
Purpose: The objective of this study was to evaluate the impact of hormone replacement
therapy (HRT) on the prognosis in endometrial cancer (EC) survivors. Methods: The research …

A predictive score for secondary cytoreductive surgery in recurrent ovarian cancer (SeC-Score): a single-centre, controlled study for preoperative patient selection

…, G Scaletta, S Lopez, A Miranda, A Di Pinto… - Annals of surgical …, 2015 - Springer
Background The standard treatments of patients with platinum-sensitive recurrent ovarian
cancer (ROC) remains poorly defined. Chemotherapy (CT) and secondary cytoreductive …